Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 13, 2000

View Archived Issues

Novartis and Noven enter marketing agreement for transdermal HRT

Company Profile: Naeja

Neurochem seeks U.K. approval to begin Fibrillex phase II/III trial

FDA grants fast track designation for RSR-13

First clinical trial begins for novel HDL therapy

Structural Bioinformatics reports small-molecule PTP1B inhibitors

FDA advises removal of phenylpropanolamine-containing products

Fujisawa continuing zenarestat development in Japan

NeoRx suspends STR trials

Cambridge Drug Discovery signs drug screening agreements with Avidex and RiboTargets

Cubist and Emisphere collaborate on oral delivery of daptomycin

Partnership formed for INOmax distribution in Japan

Novel antitumor compounds act by inhibiting VEGF receptor binding and function

Synthetic MMP inhibitor from Roche has promising antitumor/antiangiogenic activity

NCI-EORTC-AACR news: WP-769, a new oral doxorubicin analogue with an improved biological profile

Gelatinase-selective MMP inhibitor with potential clinical utility in cancer designed at Abbott

Structurally novel antitumor, antimetastatic and antiangiogenic agent with oral efficacy

Synthesis and preclinical evaluation of unique series of antitumor agents reported in Amsterdam

Trimetazidine analogue exerts significant hepatoprotective effects in I/R injury model in rats

First clinical results for UR-9825 discussed at Mycology meeting

Selective cGMP-PDE inhibitors synthesized at Nippon Soda

Novel series of anticoagulants patented by Kissei research team

Metalloproteinase inhibitors described by DuPont as particularly useful for arthritic conditions

Sankyo's new blood glucose-lowering agents described in recent patent

DuPont prepares aryl sulfonyl-based factor Xa inhibitors

Research at Neurogen leads to identification of new B2 receptor modulators

Synthesis and use of new NK3 receptor ligands presented by Neurogen

Shionogi patents several series of gelatinase A inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...